Accredo
Privacy |  HIPAA |  Terms of use |  Medco |  Contact us
   
Patients Healthcare professionals Health plans & payor clients Manufacturers Careers About Accredo
 
 
 

Patients

Getting started with Accredo
Our services
Search drug therapies
Therapy management
Nexavar® (sorafenib) - product information

Nexavar® (sorafenib)

Overview | Product information | Accredo services | Contact team


Nexavar is a prescription anticancer medicine used to treat adults with kidney cancer. Nexavar is a multi-kinase inhibitor, one of a new class of therapies often called targeted therapy. The growth of new blood vessels and the growth of new cells are two processes that do not function normally in tumors. According to the manufacturer’s website, Nexavar is designed to interfere with these processes. By reducing the supply of blood to the tumor and by slowing tumor growth, Nexavar may prevent the growth and spread of cancer.1

For more information, please visit Nexavar.com, or download the full prescribing information.


1. Nexavar Product Insert 5/08. Bayer Pharmaceuticals Corporation.


Nexavar is a registered trademark of Bayer Pharmaceuticals Corporation.

 
 
 

Quick links

Search Search drug therapies
Doctor Referral Doctor referral forms
Patient Authorization Patient authorization form
Contact Us Contact us